AVITA Medical (RCEL) Share-based Compensation Growth (1y) (2019 - 2025)
AVITA Medical (RCEL) Share-based Compensation Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -30.44% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 59.09% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | -50.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -50.93% |
| Sep 30, 2025 | -31.79% |
| Jun 30, 2025 | -33.72% |
| Mar 31, 2025 | 3.98% |
| Dec 31, 2024 | 28.88% |
| Sep 30, 2024 | 67.90% |
| Jun 30, 2024 | 252.32% |
| Mar 31, 2024 | -1.86% |
| Dec 31, 2023 | -13.30% |
| Sep 30, 2023 | 69.22% |
| Mar 31, 2023 | -9.96% |
| Sep 30, 2022 | -68.68% |
| Mar 31, 2022 | 119.95% |
| Sep 30, 2021 | 38.94% |
| Jun 30, 2021 | 171.01% |
| Mar 31, 2021 | 114.73% |
| Dec 31, 2020 | 111.92% |
| Sep 30, 2020 | 591.07% |
| Jun 30, 2020 | -778.91% |
| Mar 31, 2020 | -1,695.77% |